Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.112965 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Michael B Mumphrey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Disruption of antigen presentation via loss of major histocompatibility complex (MHC) expression is a strategy whereby cancer cells escape immune surveillance and develop resistance to immunotherapy. Here, we develop the personalized genomics algorithm Hapster and accurately call somatic mutations within the MHC genes of 10,001 primary and 2,199 metastatic tumors, creating a catalog of 1,663 non-synonymous mutations that provide key insights into MHC mutagenesis. We find that MHC class I genes are among the most frequently mutated genes in both primary and metastatic tumors, while MHC class II mutations are more restricted. Recurrent deleterious mutations are found within haplotype- and cancer-type-specific hotspots associated with distinct mutational processes. Functional classification of MHC residues reveals significant positive selection for mutations disruptive to the B2M, peptide, and T cell binding interfaces, as well as to MHC chaperones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Microbiology & Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Microbiology & Immunology, University of Michigan, Ann Arbor, MI 48109, USA; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan, Ann Arbor, MI 48109, USA; University of Mi…
- Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Patho…
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Mumphrey, M. B., Hosseini, N., Parolia, A., Geng, J., Zou, W., Raghavan, M., Chinnaiyan, A., & Cieslik, M. (2023). Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112965
Vancouver
Mumphrey MB, Hosseini N, Parolia A, Geng J, Zou W, Raghavan M, et al. Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112965
BibTeX
@article{Mumphrey2023,
author = {Mumphrey, Michael B and Hosseini, Noshad and Parolia, Abhijit and Geng, Jie and Zou, Weiping and Raghavan, Malini and Chinnaiyan, Arul and Cieslik, Marcin},
title = {Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.112965}
}
EUVIMED